Methotrexate in the treatment of inflammatory bowel disease: An 8-year retrospective study in a Canadian pediatric IBD center

Inflammatory Bowel Diseases

Volumn 17, Issue 12, 2011, Pages 2521-2526

  Willot, Stephanie ^a   Noble, Angela ^a   Deslandres, Colette ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

children; immunosuppressive therapy; inflammatory bowel disease; methotrexate

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; FOLIC ACID; INFLIXIMAB; LIVER ENZYME; MERCAPTOPURINE; METHOTREXATE; PURINE DERIVATIVE; STEROID;

ARTICLE; CANADA; CHILD; CROHN DISEASE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HARVEY BRADSHAW INDEX; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; NAUSEA; OUTCOME ASSESSMENT; PANCREATITIS; PEDIATRIC ULCERATIVE COLITIS ACTIVITY INDEX; PRIORITY JOURNAL; REMISSION; RETROSPECTIVE STUDY; SCORING SYSTEM; SIDE EFFECT; STEROID THERAPY; THROMBOCYTOPENIA; ULCERATIVE COLITIS; VOMITING;

ADOLESCENT; CANADA; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MAXIMUM TOLERATED DOSE; METHOTREXATE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053649708     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21653     Document Type: Article

References (32)

1. Prefontaine E, Sutherland LR, Macdonald JK, et al. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database Syst Rev. 2009: CD000067.
2. Gisbert JP, Linares PM, McNicholl AG, et al. Meta-analysis: the efficacy of azathioprine and mercaptopurine in ulcerative colitis. Aliment Pharmacol Ther. 2009; 30: 126-37.
3. Markowitz J, Grancher K, Kohn N, et al. A multicenter trial of 6-mercaptopurine and prednisone in children with newly diagnosed Crohn's disease. Gastroenterology. 2000; 119: 895-902.
4. Fraser AG, Orchard TR, Jewell DP,. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review. Gut. 2002; 50: 485-489. (Pubitemid 34638866)
5. Tajiri H, Tomomasa T, Yoden A, et al. Efficacy and safety of azathioprine and 6-mercaptopurine in Japanese pediatric patients with ulcerative colitis: a survey of the Japanese Society for Pediatric Inflammatory Bowel Disease. Digestion. 2008; 77: 150-154.
6. Feagan BG, Rochon J, Fedorak RN, et al. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med. 1995; 332: 292-297.
7. Feagan BG, Fedorak RN, Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med. 2000; 342: 1627-1632. (Pubitemid 30341531)
8. Oren R, Moshkowitz M, Odes S, et al. Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial. Am J Gastroenterol. 1997; 92: 2203-2209.
9. Cummings JR, Herrlinger KR, Travis SP, et al. Oral methotrexate in ulcerative colitis. Aliment Pharmacol Ther. 2005; 21: 385-389. (Pubitemid 40313940)
10. Wahed M, Louis-Auguste JR, Baxter LM, et al. Efficacy of methotrexate in Crohn's disease and ulcerative colitis patients unresponsive or intolerant to azathioprine /mercaptopurine. Aliment Pharmacol Ther. 2009; 30: 614-620.
11. Mack DR, Young R, Kaufman SS, et al. Methotrexate in patients with Crohn's disease after 6-mercaptopurine. J Pediatr. 1998; 132: 830-835. (Pubitemid 28232936)
12. Ravikumara M, Hinsberger A, Spray CH,. Role of methotrexate in the management of Crohn disease. J Pediatr Gastroenterol Nutr. 2007; 44: 427-430. (Pubitemid 46573224)
13. Turner D, Grossman AB, Rosh J, et al. Methotrexate following unsuccessful thiopurine therapy in pediatric Crohn's disease. Am J Gastroenterol. 2007; 102: 2804-2812; quiz 3, 13. (Pubitemid 350179322)
14. Uhlen S, Belbouab R, Narebski K, et al. Efficacy of methotrexate in pediatric Crohn's disease: a French multicenter study. Inflamm Bowel Dis. 2006; 12: 1053-1057. (Pubitemid 44665475)
15. Weiss B, Lerner A, Shapiro R, et al. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues. J Pediatr Gastroenterol Nutr. 2009; 48: 526-530.
16. Deslandres C,. Methotrexate: an alternative treatment in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr. 1999; 29: 520 (abstract).
17. Harvey RF, Bradshaw JM,. A simple index of Crohn's-disease activity. Lancet. 1980; 1: 514.
18. Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007; 133: 423-432. (Pubitemid 47193130)
19. Charpignon C, Beau P,. Methotrexate as single therapy in Crohn's disease: is its long-term efficacy limited? Gastroenterol Clin Biol. 2008; 32: 153-157. (Pubitemid 351625545)
20. Lemann M, Zenjari T, Bouhnik Y, et al. Methotrexate in Crohn's disease: long-term efficacy and toxicity. Am J Gastroenterol. 2000; 95: 1730-1734. (Pubitemid 30485010)
21. Herfarth HH, Osterman MT, Isaacs KL, et al. Efficacy of methotrexate in ulcerative colitis: failure or promise. Inflamm Bowel Dis. 2010; 16: 1421-1430.
22. Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med. 1994; 121: 833-841.
23. Baert F, Noman M, Vermeire S, et al. Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med. 2003; 348: 601-608. (Pubitemid 36204954)
24. Vermeire S, Noman M, Van Assche G, et al. Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn's disease. Gut. 2007; 56: 1226-1231. (Pubitemid 47300423)
25. Shale M, Kanfer E, Panaccione R, et al. Hepatosplenic T cell lymphoma in inflammatory bowel disease. Gut. 2008; 57: 1639-1641.
26. van den Brande JM, Peppelenbosch MP, Hommes DW,. Synergistic effect of methotrexate and infliximab on activated lymphocyte apoptosis. Inflamm Bowel Dis. 2007; 13: 118-119. (Pubitemid 46080018)
27. Maini RN, Breedveld FC, Kalden JR, et al. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum. 1998; 41: 1552-1563. (Pubitemid 28459913)
28. Schroder O, Blumenstein I, Stein J,. Combining infliximab with methotrexate for the induction and maintenance of remission in refractory Crohn's disease: a controlled pilot study. Eur J Gastroenterol Hepatol. 2006; 18: 11-16. (Pubitemid 43004875)
29. Feagan B, McDonald JW, Panaccione R, et al. A randomized trial of methotrexate in combination with infliximab for Crohn's disease. Commit DDW. 2008 Abstract 682c.
30. Ardizzone S, Bollani S, Manzionna G, et al. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig Liver Dis. 2003; 35: 619-627. (Pubitemid 41110872)
31. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med. 2010; 362: 1383-1395.
32. Candy S, Wright J, Gerber M, et al. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut. 1995; 37: 674-678.